"Effectiveness of Dual-Wavelength Laser Therapy in Third Molar Extraction Pain, Swelling, and Trismus"
Molar, Third, Low-level Laser Therapy
About this trial
This is an interventional supportive care trial for Molar, Third focused on measuring photobiomodulation,, Impacted third molar, Pain, Edema
Eligibility Criteria
Inclusion Criteria: Volunteer ASA I individuals aged 18-40 years Exclusion Criteria: Those who are pregnant or lactating, Those receiving anticoagulant or antiaggregant medication, Those who have received radiotherapy to the head and face area, Those who are allergic to local anesthetics and prescribed drugs
Sites / Locations
- Gaziosmanpasa University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Dual wavelength low dose laser
Plasebo
Immediately after suturing the patient, a low-dose laser application was performed on the laser group using the square probe (16 J/min) of the locally produced GRR laser device (Ankara, Turkey) for 5 minutes. The device combines a 22 mW GaAlAs infrared laser with a wavelength of 904 nm and a 10 mW red laser with a wavelength of 650 nm. The square probe contains 5 red lasers and 4 infrared lasers, covering an area of 30mm X 30mm.
Laser probe will be applied to the control group patients, but the device was not operated.